Kenvue Inc.

Equities

KVUE

US49177J1025

Personal Products

Market Closed - Nyse 04:00:02 2024-09-11 pm EDT 5-day change 1st Jan Change
23.09 USD +0.17% Intraday chart for Kenvue Inc. +2.58% +7.25%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Analyst recommendations: Verizon, Nucor, Colgate-Palmolive, Kimberly-Clark... Our Logo
Deutsche Bank Adjusts Price Target on Kenvue to $25 From $24 MT
Transcript : Kenvue Inc. Presents at Barclays 17th Annual Global Consumer Staples Conference, Sep-05-2024 03:00 PM
Kenvue Secures Legal Win as Judge Dismisses Class Action Lawsuit Over Rapid Release Gelcaps MT
Tylenol maker defeats lawsuit over labeling RE
Kenvue Inc. Introduces Patented Micro-Peptide Technology with Neutrogena Collagen Bank Launch CI
Layoffs pile up in US, Canada as companies uncertain of economy RE
Layoffs pile up in US, Canada as companies uncertain of economy RE
UBS Adjusts Kenvue Price Target to $22 From $20, Maintains Neutral Rating MT
JPMorgan Adjusts Price Target on Kenvue to $24 From $22 MT
Citigroup Adjusts Price Target on Kenvue to $21 From $20 MT
Goldman Sachs Adjusts Price Target on Kenvue to $21 From $19 MT
Deutsche Bank Adjusts Price Target on Kenvue to $24 From $23 MT
Equity Markets Rebound; Yields Jump MT
Equity Markets Rebound; Yields Jump MT
Tranche Update on Kenvue Inc.'s Equity Buyback Plan announced on October 26, 2023. CI
Sector Update: Health Care Stocks Rise Late Afternoon MT
Sector Update: Health Care MT
Equity Markets Rebound Intraday; Yields Surge MT
Kenvue Shares Jump After Q2 Results Beat Views MT
Wall St bounces back after global stocks rout RE
Sector Update: Consumer Stocks Flat to Higher Pre-Bell Tuesday MT
Sector Update: Consumer MT
Transcript : Kenvue Inc., Q2 2024 Earnings Call, Aug 06, 2024
Kenvue Q2 Adjusted Earnings Increase, Revenue Slips MT
Chart Kenvue Inc.
More charts
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: - health products: for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - body care products: hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.); - other: notably oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.). Product marketing is assured through direct sales, distributors and the Internet.
Employees
22,000
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
23.09USD
Average target price
22.56USD
Spread / Average Target
-2.30%
Consensus
  1. Stock Market
  2. Equities
  3. KVUE Stock
  4. News Kenvue Inc.
  5. Equity Markets Rebound; Yields Jump
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW